Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related ...

Spot and Tubular data show prescription immunology brands continued to dominate TV, while seasonal OTC brands found scale on ...

So first, let's consider Viking's story so far. The company is working on a dual GLP-1/GIP receptor agonist in injectable and oral formats. Injectable VK2735 is involved in a phase 3 trial right now, ...

Nine states have been pursuing the idea of prescription drug affordability boards. Maryland's board just set limits on the ...

Millions of older Americans may have access for the first time to obesity drugs at a low price of $50 a month starting in ...

One in eight American adults is taking GLP-1s. What does that mean for how we relate to our food, bodies and one another? This is an edited transcript of “The Ezra Klein Show.” You can listen to the ...

A new Apple TV 4K is rumored to launch this fall with AI support, and the latest Netflix feature offers a helpful example of how AI might benefit the Apple TV. Apple Intelligence is rumored to hit ...

iPhone owners could receive up to $95 under a proposed $250 million settlement resolving claims that Apple misled customers about Siri's artificial intelligence features, according to a recent court ...

Keeping up with Kris Jenner’s weight loss. The reality star admitted to “She MD” podcast listeners on Tuesday that she tried Ozempic before it was trendy. “We tried it once when no one knew what it ...

Today, Grinding Gear Games announced Path of Exile 2 patch 0.5, "Return of the Ancients," which will launch on May 29. It’s the "largest update" the studio has ever released, and it completely revamps ...

Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that delivers medications directly to customers' homes, is expanding access to Novo Nordisk's Ozempic® pill, the only FDA-approved oral ...

Novo hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales, saying it now expects adjusted sales and profit to contract between 4% and 12%. Novo said ...